logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Miguel Gil-Gil

instituto catalan de oncologia
H指数:36
被引数:6,818

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic thymidine kinase activity independently captures treatment-specific biological response and is independently associated with outcomes in endocrine-resistant HR+/HER2− metastatic breast cancer: a translational analysis of the GEICAM/2013-02 PEARL trial

动态胸苷激酶活性独立捕获治疗特异性的生物学反应，并与内分泌耐药的HR+/HER2−转移性乳腺癌的结局独立相关：GEICAM/2013-02 PEARL试验的转化分析

European Journal of Cancer
IF7.1
2026-05-250
OAAI
Ángel Guerrero-Zotano; Miguel Gil-Gil; Amy Williams; Manuel Ruiz-Borrego; Hanna Ritzén; Eva María Ciruelos; Montserrat Muñoz; Begoña Bermejo; Mireia Margelí; Antonio Antón; Zsuzsanna Kahan; Tibor Csöszi; Laura Murillo; Serafín Morales Murillo; Istvan Lang; Cristina Reboredo Rendo; Emilio Alba; Pablo Álvarez; Juan de la Haba-Rodriguez; Isabel Álvarez
Outcomes of Hormone receptor-positive/HER2-negative early breast cancer patients by risk of recurrence groups focusing on the intermediate-risk group: Retrospective analysis from GEICAM studies

激素受体阳性/HER2阴性早期乳腺癌患者按复发风险分组的结局：聚焦于中危组：GEICAM研究的回顾性分析

Breast Cancer Research
IF5.6
2026-05-250
OAAI
Sonia Servitja; Eva Carrasco; Raquel Andrés; Álvaro Rodríguez-Lescure; Miguel Martín; Manuel Ruiz-Borrego; Ángel Guerrero; Begoña Bermejo; Antonio Antón; Montserrat Muñoz; Mireia Margeli; Isabel Álvarez; Luis Antonio Fernández; Jose Ponce; Josefina Cruz; Purificación Martínez; Sara López-Tarruella; Margarita Amenedo; Andrea Blasco; Óscar Polonio; Miguel Gil-Gil
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease

曲妥珠单抗德鲁替康在激素受体阳性、HER2低/超低表达转移性乳腺癌（DESTINY-Breast06）：基于先前一线内分泌联合CDK4/6抑制剂治疗至进展时间和基线疾病负担的疗效分析

Annals of Oncology
IF65.4
2026-03-020
OAAI
G. Curigliano; X. Hu; R. Dent; K. Yonemori; C.H. Barrios; J.-Y. Pierga; F. Puglisi; J.-M. Ferrero; K.H. Jung; N.A. Bagegni; J. Collignon; M. Gil-Gil; X. Wu; A. Andrzejuk-Ćwik; M. Schwaederle; S. Anand; A. Bardia
Palbociclib with adjuvant endocrine therapy in early breast cancer: five-year follow up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)

帕博西利联合辅助内分泌疗法在早期乳腺癌中的应用：全球多中心、开放标签、随机III期PALLAS试验（ABCSG-42/AFT-05/PrE0109/BIG-14-13）五年随访分析

Annals of Oncology
IF65.4
2025-10-170
OAAI
E.L. Mayer; D. Hlauschek; M. Gnant; P.J. O'Brien; M. Bellet-Ezquerra; M.P. Goetz; M. Ruiz-Borrego; A. Chan; K. Clifton; D. Egle; D. Lake; P. Cabrera; T. Mamounas; G. Pristauz-Telsnigg; Z. Dayao; M. Gil Gil; D. Cameron; T. Traina; P.G. Morris; D. Sabanathan; G. Rinnerthaler; J. Meisel; A. Prat; A.C. Wolff; L-M. Tseng; C. Isaacs; C.F. Singer; G. Rubovszky; T. Foukakis; J. Jassem; E.P. Winer; M. Vetter; J. Federmann; O. Metzger; C. Schurmans; E. Gauthier; D.R. Lu; C. Fesl; A. Dueck; A. DeMichele
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial☆

在PARSIFAL试验中，对内分泌敏感、激素受体阳性/HER2阴性晚期乳腺癌患者使用palbociclib联合fulvestrant或letrozole的延长随访研究☆

ESMO Open
IF8.3
2025-07-010
PRE
A. Llombart-Cussac; J.M. Pérez-García; M. Bellet; F. Dalenc; M. Gil-Gil; M. Ruiz-Borrego; J. Gavila; P. Schmid; P. Zamora; D. Wheatley; E. Martínez-de Dueñas; K. Amillano; S. Di Cosimo; A. Anton; P. Cottu; E. Shimizu; M. Fernandez; M. Sampayo-Cordero; J. Cortés
Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial

D-BIOMARK临床试验的窗口期研究结果：Denosumab作为免疫调节剂在HER2阴性早期乳腺癌中的应用

BREAST CANCER RESEARCH
IF5.6
2025-05-120
OA
Vethencourt, Andrea; Trinidad, Eva M.; Dorca, Eduard; Petit, Anna; Soler-Monso, M. Teresa; Ciscar, Marina; Barranco, Alexandra; Perez-Chacon, Gema; Jimenez, Maria; Rodriguez, Mario; Gomez-Aleza, Clara; Purqueras, Elvira; Hernandez-Jimenez, Enrique; Urruticoechea, Ander; Morilla, Idoia; Subirana, Isaac; Garcia-Tejedor, Amparo; Gil-Gil, Miguel; Pernas, Sonia; Falo, Catalina; Gonzalez-Suarez, Eva
Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Catala d'Oncologia Breast Cancer Observational Cohort Study

综合临床特征分析及长期随访：Institut Catala d'Oncologia乳腺癌观察性队列研究

CANCERS
IF4.4
2025-04-190
OA
Pla, Helena; Fullana, Bartomeu; Esteve, Anna; Fort-Culillas, Roser; Ferrando-Diez, Angelica; Fernandez-Ortega, Adela; Pous, Anna; Stradella, Agostina; Villanueva-Vazquez, Rafael; Cirauqui, Beatriz; Falo, Catalina; Martinez-Perez, Evelyn; Molina, Guadalupe; del Barco, Sonia; Eraso, Arantxa; Margeli, Mireia; Vinas, Gemma; Gil-Gil, Miguel; Petriz, Lourdes; Pernas, Sonia
Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?

评估真实世界数据中乳腺癌患者口服内分泌治疗依从性的质量：真实世界数据有多真实？

CANCERS
IF4.4
2025-01-090
OA
Navarro-Sabate, A.; Font, R.; Espinas, J. A.; Sola, J.; Martinez-Soler, F.; Gil-Gil, M.; Vinas, G.; Tibau, A.; Borrell, M.; Segui, M.; Margeli, M.; Servitja, S.; Perez, C.; Domenech, M.; Nava, M.; Marin, M.; Gonzalez, S.; Borras, J. M.
Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study
ESMO OPEN
IF8.3
2024-10-010
OAAI
Guerrero-Zotano, A.; Perez-Garcia, J. M.; Ruiz-Borrego, M.; Bermejo, B.; Gil-Gil, M.; de la Haba, J.; Conejo, E. Alba; Quiroga, V; Caranana, V; Urruticoechea, A.; Morales, S.; Bellet, M.; Anton, A.; Fernandez-Abad, M.; Sanchez-Rovira, P.; Calabuig, L.; Perez-Escuredo, J.; Sampayo-Cordero, M.; Cortes, J.; Llombart-Cussac, A.
Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer
BREAST
IF7.9
2024-08-010
OAAI
Di Cosimo, Serena; Perez-Garcia, Jose Manuel; Bellet, Meritxell; Dalenc, Florence; Gil, Miguel J. Gil; Ruiz-Borrego, Manuel; Gavila, Joaquin; Aguirre, Elena; Schmid, Peter; Marme, Frederik; Gligorov, Joseph; Schneeweiss, Andreas; Albanell, Joan; Zamora, Pilar; Wheatley, Duncan; de Duenas, Eduardo Martinez; Amillano, Kepa; Shimizu, Eileen; Sampayo-Cordero, Miguel; Cortes, Javier; Llombart-Cussac, Antonio
PARSIFAL-LONG: Extended follow-up of hormone receptor-positive/ HER2-negative advanced breast cancer patients treated with fulvestrant and palbociclib vs. letrozole and palbociclib in the PARSIFAL study
CANCER RESEARCH
IF16.6
2024-05-022
PRE
Llombart-Cussac, Antonio; Perez-Garcia, Jose Manuel; Bellet-Ezquerra, Meritxell; Dalenc, Florence; Gil-Gil, Miguel; Ruiz-Borrego, Manuel; Gavila, Joaquin; Schmid, Peter; Zamora, Pilar; Wheatley, Duncan; Martinez-de Duenas, Eduardo; Amillano, Kepa; Anton, Antonio; Cottu, Paul; Vinas, Gemma; Petit, Thierry; Tesarova, Petra; Cueva, Juan; Colleoni, Marco; del Prado, Maria Purificacion Martinez; Andres, Raquel; Cabo, Marta Diaz; Victorino, Susana; Sampayo-Cordero, Miguel; Cortes, Javier
Randomized Phase II trial evaluating three antidiarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gil-Gil, Miguel; Martin, Miguel; Carrasco, Eva; Galve, Elena; Martinez-Janez, Noelia; Gonzalez-Santiago, Santiago; Adamo, Barbara; Valero, Maria; Martinez, Clara; Guerrero, Angel; Novoa, Silvia Antolin; Ruiz-Borrego, Manuel; Blancas, Isabel; Andres, Raquel; Alonso-Romero, Jose L.; Andrea, Vethencourt; Chacon, J. Ignacio; Chavarria, Natalia; Espinosa, Enrique; Hernando, Blanca; Adrover, Encarnacion; Rojo, Federico; Casas, Maribel; McCulloch, Leanne; Vedovato, Jean-Claude
ctDNA-based DNADX in hormone receptorpositive and HER2-negative (HR+/HER2-) advanced breast cancer following endocrine therapy and CDK4/6 inhibition: a correlative analysis from the randomized phase 2 PARSIFAL trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Braso-Maristany, Fara; Cortes, Javier; Perez-Garcia, Jose Manuel; Vega-Leon, Rosario; Pare, Laia; Villacampa, Guillermo; Matito, Judit; Pardo, Francisco; Gomez-Rey, Marina; Mancino, Mario; Martinez-Garcia, Elena; Gallardo, Carmen Mora; Mina, Leonardo; Dalenc, Florence; Bellet-Ezquerra, Meritxell; Ruiz-Borrego, Manuel; Gil-Gil, Miguel; Schmid, Peter; Perou, Charles M.; Parker, Joel S.; Villagrasa, Patricia; Vivancos, Ana; Prat, Aleix; Llombart-Cussac, Antonio
Lower pre-treatment B-cell gene expression signatures correspond with improved overall survival with palbociclib plus endocrine therapy in HR+/HER2-metastatic breast cancer: a biomarker analysis from the GEICAM/2013-02 PEARL trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Agrawal, Yash; Fernandez-Martinez, Aranzazu; Gil-Gil, Miguel; Zielinski, Christoph; Ruiz-Borrego, Manuel; Ciruelos, Eva; Munoz, Montserrat; Margeli, Mireia; Bermejo, Begona; Anton, Antonio; Kahan, Zsuzsanna; Csoszi, Tibor; Alonso-Romero, Jose L.; Garcia-Saenz, Jose Angel; Sanchez-Rovira, Pedro; Alvarez, Elena; Chacon, J. Ignacio; Gonzalez-Santiago, Santiago; Rodriguez, Cesar A.; Servitja, Sonia; Pfefferle, Adam D.; Herranz, Jesus; Liu, Yuan; Carey, Lisa A.; Romero-Camarero, Isabel; Caballero, Rosalia; Perou, Charles M.; Martin, Miguel
Denosumab as an enhancer of the immune infiltrate in hormone receptor-positive early breast cancer. Subgroup analysis from the D-Biomark window-of-opportunity clinical trial (NCT03691311)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Vethencourt, Andrea; Trinidad, Eva; Dorca, Eduard; Petit, Anna; Soler-Monso, Teresa; Stradella, Agostina; Capo, Cristina; Urriticoechea, Ander; Matas, Marta; Perez-Chacon, Gema; Jimenez, Maria; Ciscar, Marina; Brizzi, Emilia; Alcaide, Gonzalo Soria; Gomez, Gonzalo; Pineiro, Elena; Purqueras, Elvira; Garcia, Amparo; Iserte, Ariadna; Pla, M. Jesus; Campos, Miriam; Gil-Gil, Miguel; Pernas, Sonia; Gonzalez-Suarez, Eva; Falo, Catalina
Body Mass Index and Treatment Efficacy in advanced Luminal Breast Cancer: Insights from the GEICAM/2013-02 (PEARL) trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Alva, Manuel; Lopez-Tarruella, Sara; Zielinski, Christoph; Ruiz-Borrego, Manuel; Turner, Nicholas; Ciruelos, Eva; Munoz, Montserrat; Bermejo, Begona; Margeli, Mireia; Anton, Antonio; Kahan, Zsuzsanna; Csoszi, Tibor; Casas, Maribel; Murillo, Laura; Murillo, Serafin Morales; Alba, Emilio; Yam, Einav Nili-Gal; Guerrero, Angel; Calvo, Lourdes; de la Haba-Rodriguez, Juan; Ramos, Manuel; Alvarez, Isabel; Garcia-Palomo, Andres; Koehler, Maria; Garcia-Saenz, Jose Angel; Chacon, J. Ignacio; Swift, Claire; Thallinger, Christiane; Gil-Gil, Miguel; Martin, Miguel
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy
NPJ BREAST CANCER
IF7.6
2024-03-063
OAAI
Pascual, Tomas; Fernandez-Martinez, Aranzazu; Agrawal, Yash; Pfefferle, Adam D.; Chic, Nuria; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pare, Laia; Villacampa, Guillermo; Saura, Cristina; Hernando, Cristina; Munoz, Montserrat; Galvan, Patricia; Gonzalez-Farre, Xavier; Oliveira, Mafalda; Gil-Gil, Miguel; Ciruelos, Eva; Villagrasa, Patricia; Gavila, Joaquin; Prat, Aleix; Perou, Charles M.
Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
FRONTIERS IN ONCOLOGY
IF3.3
2023-08-0913
OAAI
Garcia-Tejedor, Amparo; Ortega-Exposito, Carlos; Salinas, Sira; Luzardo-Gonzalez, Ana; Falo, Catalina; Martinez-Perez, Evelyn; Perez-Montero, Hector; Soler-Monso, M. Teresa; Bajen, Maria-Teresa; Benitez, Ana; Ortega, Raul; Petit, Anna; Guma, Anna; Campos, Miriam; Pla, Maria J.; Pernas, Sonia; Penafiel, Judith; Yeste, Carlos; Gil-Gil, Miguel; Guedea, Ferran; Ponce, Jordi; Laplana, Maria
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact
BREAST CANCER RESEARCH AND TREATMENT
IF3
2023-04-120
OA
Garcia-Tejedor, Amparo; Falo, Catalina; Fernandez-Gonzalez, Sergi; Laplana, Maria; Gil-Gil, Miguel; Soler-Monso, Teresa; Martinez-Perez, Evelyn; Calvo, Iris; Calpelo, Hugo; Bajen, Maria-Teresa; Benitez, Ana; Ortega, Raul; Petit, Anna; Guma, Anna; Campos, Miriam; Stradella, Agostina; Lopez-Ojeda, Ana; Ponce, Jordi; Pla, Maria J.; Pernas, Sonia

研究方向

暂未获取到该数据
M
Mireia Margelí Vila
H 指数:31论文数:428被引数:3,602
C
Catalina Falo
H 指数:14论文数:90被引数:440
M
Montserrat Muñoz-Mateu
H 指数:50论文数:620被引数:9,873
B
Begoña Bermejo
H 指数:41论文数:635被引数:6,634
A
Agostina Stradella
H 指数:20论文数:145被引数:1,422
E
Eva Ciruelos
H 指数:54论文数:695被引数:1.9万
E
Emilio Alba
H 指数:53论文数:488被引数:1.2万
S
Serafín Morales
H 指数:30论文数:338被引数:6,684
A
Antonio Llombart‐Cussac
H 指数:59论文数:698被引数:1.6万
M
Manuel Ruíz‐Borrego
H 指数:33论文数:249被引数:5,894